RZLT INVESTIGATION: Rezolute, Inc. Investors Should Contact Block & Leviton LLP To Potentially Recover Losses

Core Viewpoint - Rezolute, Inc. (NASDAQ: RZLT) experienced a significant decline in share price, falling over 85% after the failure of its Phase 3 sunRIZE study in congenital hyperinsulinism, which did not meet its primary or key secondary endpoints. This has raised concerns about potential securities law violations due to misleading statements made by the company regarding earlier data and program outlook [2][4]. Group 1: Company Performance - The share price of Rezolute, Inc. dropped more than 85% on December 11, 2025, following the announcement of the failed clinical trial results [2]. - The Phase 3 sunRIZE study aimed at treating congenital hyperinsulinism did not achieve its primary or key secondary endpoints, leading to investor losses [2]. Group 2: Legal Investigation - Block & Leviton is investigating Rezolute, Inc. for potential securities law violations and may file an action to recover losses for affected investors [4]. - Investors who purchased common stock in Rezolute, Inc. and experienced a decline in share value may be eligible to participate in the investigation, regardless of whether they sold their shares [3]. Group 3: Investor Support - Block & Leviton encourages investors who have lost money to contact them for assistance in recovering losses [5]. - The firm is recognized as a leading securities class action firm, having recovered billions for defrauded investors through litigation [7].